Triple synchronous cutaneous melanoma: A clinical, dermoscopic, and genetic case study

Dermatologic Surgery

Volumn 33, Issue 4, 2007, Pages 488-491

  De Giorgi, Vincenzo ^a   Salvini, Camilla ^a   Sestini, Serena ^a   Vignoli, Marina ^a   Sestini, Roberta ^a   Papi, Federica ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CYCLIN DEPENDENT KINASE INHIBITOR 2 A; DNA; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER REGRESSION; CARCINOMA IN SITU; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; EPILUMINESCENCE MICROSCOPY; FAMILY HISTORY; FEMALE; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; MELANOMA; PATIENT INFORMATION; PERIODIC MEDICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN DEFECT; SKIN METASTASIS; SKIN PIGMENTATION; TISSUE SECTION;

ADULT; DERMOSCOPY; FEMALE; HUMANS; MELANOMA; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS;

EID: 34147123152     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33098.x     Document Type: Article

References (9)

1. Burden AD, Vestey JP, Sirel JM, et al. Multiple primary melanoma: risk factors and prognostic implications. BMJ 1994;309-376.
2. Kang S, Barnhill RL, Mihm MC, et al. Multiple primary cutaneous melanomas. Cancer 1992;70:1911-6.
3. Difronzo LA, Wanek LA, Elashoff R, et al. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999;6:705-11.
4. Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003;97:639-43.
5. Carli P, De Giorgi V, Chiarugi A, et al. Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol 2002;41:583-5.
6. Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med 1998;338:879-87.
7. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-47.
8. Puig S, Malvehy J, Badenas C, et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005;23:3043-51.
9. Wasko R, Wolun-Cholewa M, Bolko P, Kotwicka M. Effect of bromocriptine on cell apoptosis and proliferation in GH3 cell culture. Neuro Endocrinol Lett 2004;25:223-8.